APA (7th ed.) Citation

Wang, Y., & Li, Y. (2025). Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”. Elsevier.

Chicago Style (17th ed.) Citation

Wang, Yan, and Yansong Li. Comment on “Efficacy and Safety of Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy with Secondary Cytoreduction for Platinum Resistant Recurrent Ovarian Cancer: A Single-center Retrospective Cohort Study”. Elsevier, 2025.

MLA (9th ed.) Citation

Wang, Yan, and Yansong Li. Comment on “Efficacy and Safety of Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy with Secondary Cytoreduction for Platinum Resistant Recurrent Ovarian Cancer: A Single-center Retrospective Cohort Study”. Elsevier, 2025.